Predict your next investment

MEDIA (TRADITIONAL) | Television

See what CB Insights has to offer

Investors Count

1

CaerVision - Asthma & Allergy Network Funding, CaerVision - Asthma & Allergy Network Valuation & CaerVision - Asthma & Allergy Network Revenue

1 Fundings

CaerVision - Asthma & Allergy Network's latest funding round was a Acquired Unit for on January 9, 2014.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/9/2014

Acquired Unit

$0.00B

((9.99x))

FY 1234

1

Date

1/9/2014

Round

Acquired Unit

Amount

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

Sources

1

CaerVision - Asthma & Allergy Network Investors

1 Investors

CaerVision - Asthma & Allergy Network has 1 investors. AccentHealth invested in CaerVision - Asthma & Allergy Network's Acquired Unit funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/9/2014

1/9/2014

1
Acquired Unit

Corporation

Florida

First funding

1/9/2014

Last Funding

1/9/2014

Investor

Rounds

1
Acquired Unit

Board Seats

Type

Corporation

Location

Florida

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.